Should I get plasma free metanephrines or a 24-hour urine collection for fractionated metanephrines to measure metanephrine levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Plasma Free Metanephrines vs. 24-Hour Urine Collection for Measuring Metanephrine Levels

Plasma free metanephrines is the preferred first-line test for measuring metanephrine levels due to its superior sensitivity (96-100%) compared to 24-hour urine collection (86-97%). 1

Diagnostic Performance Comparison

Plasma Free Metanephrines

  • Sensitivity: 96-100% 1
  • Specificity: 89-98% 1
  • Advantages:
    • Higher sensitivity for detecting pheochromocytoma 2
    • No false-negative results in most studies 2
    • More convenient for patients (single blood draw vs. 24-hour collection)
    • Particularly valuable in high-risk patients with familial endocrine syndromes 3
    • Preferred for patients who cannot reliably collect 24-hour urine 1

24-Hour Urine Fractionated Metanephrines

  • Sensitivity: 86-97% 1
  • Specificity: 86-95% 1
  • Advantages:
    • Fewer false-positive results (higher specificity) 3
    • Better for low-risk patients where false positives are more concerning 3
    • Acceptable alternative once patients are continent of urine 4

Clinical Decision Algorithm

  1. For most patients: Use plasma free metanephrines as the first-line test 4, 1

    • Requires proper collection technique: patient should be lying supine for 30 minutes before collection 1
    • Avoid interfering foods and medications prior to testing 1
  2. For specific patient populations:

    • High-risk patients (familial syndromes, known genetic mutations): Plasma free metanephrines 3
    • Low-risk patients (where false positives are more concerning): 24-hour urine collection may be preferred 3
    • Children or incontinent patients: Plasma free metanephrines 4
  3. Interpretation of results:

    • Plasma metanephrines ≥4 times upper limit of normal: Consistent with disease, proceed with imaging 4, 1
    • Plasma metanephrines 2-4 times upper limit of normal: Repeat testing in 2 months 4
    • Marginally elevated levels: Repeat testing in 6 months or consider clonidine suppression test 4, 1

Important Considerations

  • Normal plasma metanephrine levels effectively exclude pheochromocytoma, whereas normal urine levels may still miss some cases 2
  • Adrenal pheochromocytomas can sometimes be missed by urinary testing, particularly in patients with familial syndromes 3
  • For screening patients with adrenal incidentalomas that display ≥10 HU on non-contrast CT or who have signs/symptoms of catecholamine excess, either plasma or 24-hour urinary metanephrines are acceptable 4

Potential Pitfalls

  • False positives with plasma testing can occur due to:

    • Medications (tricyclic antidepressants, MAO inhibitors, sympathomimetics)
    • Stress or acute illness
    • Improper collection technique (not resting supine before collection)
    • Failure to fast
  • False negatives with urine testing can occur due to:

    • Incomplete 24-hour collection
    • Small tumors, especially in familial syndromes
    • Intermittent catecholamine secretion

For optimal results, ensure proper collection techniques and patient preparation regardless of which test is chosen.

References

Guideline

Diagnosis and Management of Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Plasma metanephrines in the diagnosis of pheochromocytoma.

Annals of internal medicine, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.